|
ORC3L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.377900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.796160E-03 |
| Normal-vs-Stage2 |
2.08309999999434E-05 |
| Normal-vs-Stage3 |
1.557580E-03 |
| Normal-vs-Stage4 |
5.079900E-02 |
| Stage1-vs-Stage2 |
1.030380E-02 |
| Stage1-vs-Stage3 |
5.192200E-01 |
| Stage1-vs-Stage4 |
8.475000E-01 |
| Stage2-vs-Stage3 |
6.541800E-02 |
| Stage2-vs-Stage4 |
5.799800E-02 |
| Stage3-vs-Stage4 |
5.569600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.558580E-04 |
| Normal-vs-AfricanAmerican |
2.190100E-02 |
| Normal-vs-Asian |
3.551000E-01 |
| Caucasian-vs-AfricanAmerican |
9.577000E-01 |
| Caucasian-vs-Asian |
2.097800E-02 |
| AfricanAmerican-vs-Asian |
1.825960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.421100E-03 |
| Normal-vs-Female |
4.157000E-04 |
| Male-vs-Female |
6.565000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.115810E-02 |
| Normal-vs-Age(41-60Yrs) |
1.950660E-04 |
| Normal-vs-Age(61-80Yrs) |
1.984190E-03 |
| Normal-vs-Age(81-100Yrs) |
1.575870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.136210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.612180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.851600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.366000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.061200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.721400E-01 |
| Classical-VS-Follicular |
8.594400E-02 |
| Classical-VS-Other |
1.096040E-01 |
| Classical-VS-Normal |
2.880200E-03 |
| Tall-VS-Follicular |
4.053600E-01 |
| Tall-VS-Other |
7.272200E-02 |
| Tall-VS-Normal |
1.554200E-02 |
| Follicular-VS-Other |
7.001800E-02 |
| Follicular-VS-Normal |
6.820200E-04 |
| Other-VS-Normal |
7.419400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.371900E-04 |
| Normal-vs-N1 |
4.394400E-01 |
| N0-vs-N1 |
1.576440E-02 |
|
|
